Company

Armata Pharmaceuticals, Inc. (ARMP)

Standardized SEC financial data for Armata Pharmaceuticals, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000921114 · NYSE · Biological Products, (No Diagnostic Substances).

Revenue growth (YoY)

404.9%

Return on equity

79.5%

Free cash flow

-$26.3M

Current ratio

1.19×

EPS (diluted)

$-4.80

Ratios for fiscal year 2014, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
R&D expense	$14.4M	$20.0M	$35.0M	$33.8M	$34.4M	$23.7M
SG&A expense	$8.0M	$8.3M	$7.4M	$11.6M	$13.2M	$12.4M
Operating income	-$21.6M	-$23.8M	-$36.9M	-$40.9M	-$42.4M	-$36.6M
EBITDA	—	—

Standardized from Armata Pharmaceuticals, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$10.8M	$11.5M	$20.8M	$19.2M	$14.8M	$14.1M
Total current assets	$10.8M	$15.0M	$27.0M	$19.2M	$11.3M	$10.7M
Property, plant & equipment	$2.0M	$2.2M	$3.6M	$12.6M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$18.3M	-$23.6M	-$32.5M	-$47.4M	-$37.6M	-$25.8M
Capital expenditures	$824K	$1.3M	$2.2M	$8.1M	$1.9M	$542K
Free cash flow	-$19.1M	-$24.9M	-$34.7M	-$55.6M

Get ARMP data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ARMP/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ARMP/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View ARMP filings on SEC EDGAR →